hepatitis

Risk of hepatitis B reactivation in COVID-19 patients receiving corticosteroid therapy Abstract COVID-19 and HBV are significant public health issues, and managing their co-infection remains unclear. Corticosteroid therapy improves survival in severe COVID-19 but may increase the risk of HBV...

Comparative analysis of SNPs associated with COVID-19 and chronic liver disease identifies DPP9 as a candidate genetic marker for Long COVID Introduction Long COVID is a multisystemic condition characterized by persistent symptoms after acute SARS-CoV-2 infection, whose biological mechanisms...

https://www.msn.com/en-gb/health/other/millions-in-europe-unknowingly-living-with-hepatitis-health-authorities-warn/ar-AA1JrikR?ocid=msedgntp&pc=U531&cvid=29524ff7b66e4585a3cbb2067f8b6e86&ei=51

Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19 Felix Röttele; Andreas Zollner; Carolin Mogler; Muhammed Yuksel; Cigdem Arikan; Vivien Karl; Judith Helene Aberle; Stephan...

Liver abnormalities following SARS-CoV-2 infection in children under 10 years of age Pauline Terebuh; Veronica R Olaker; Ellen K Kendall; David C Kaelber; Rong Xu; Pamela B Davis Objective: Beginning in October 2021 in the US and elsewhere, cases of severe pediatric hepatitis of unknown...

Open access, https://onlinelibrary.wiley.com/doi/full/10.1111/jcmm.14951